About the Beijing AI Center

The Beijing AI Center is a new strategic investment by AstraZeneca to accelerate drug discovery through AI. The center brings together AI researchers, computational scientists, and platform engineers to apply foundation models, agentic AI, and large-scale scientific computing to real R&D problems. Situated in one of the world’s most dynamic AI talent markets, it operates at the intersection of biologics discovery, computational chemistry, and AI-driven drug discovery.

The center is structured around three pillars: Discovery verticals (therapeutic design and preclinical predictions), Data & AI Platforms, and Ecosystem Partnerships with leading Chinese academic institutions and AI companies.

About the Role

This role is the strategic and operational backbone of the Beijing AI Center. You sit alongside the center lead and function leads as a trusted thought partner and execution engine — making the center run bette...